Group One Trading’s Acura Pharmaceuticals ACUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-807
| Closed | -$1K | – | 5376 |
|
|
2016
Q4 | $1K | Hold |
807
| – | – | ﹤0.01% | 4367 |
|
|
2016
Q3 | $1K | Hold |
807
| – | – | ﹤0.01% | 4481 |
|
|
2016
Q2 | $1K | Sell |
807
-1,400
| -63% | -$3.61K | ﹤0.01% | 4555 |
|
|
2016
Q1 | $6K | Buy |
2,207
+100
| +5% | +$213 | ﹤0.01% | 4183 |
|
|
2015
Q4 | $5K | Buy |
2,107
+2,000
| +1,869% | +$4.86K | ﹤0.01% | 4391 |
|
|
2015
Q3 | $0 | Sell |
107
-1
| -0.9% | -$3 | ﹤0.01% | 5523 |
|
|
2015
Q2 | $1K | Sell |
108
-27
| -20% | -$112 | ﹤0.01% | 4780 |
|
|
2015
Q1 | $1K | Sell |
135
-40
| -23% | -$128 | ﹤0.01% | 4675 |
|
|
2014
Q4 | $0 | Buy |
+175
| New | +$484 | ﹤0.01% | 5610 |
|
|
2014
Q2 | – | Sell |
-455
| Closed | -$2.76K | – | 5743 |
|
|
2014
Q1 | $3K | Buy |
455
+360
| +379% | +$3.13K | ﹤0.01% | 4959 |
|
|
2013
Q4 | $1K | Sell |
95
-920
| -91% | -$7.77K | ﹤0.01% | 5151 |
|
|
2013
Q3 | $10K | Buy |
1,015
+81
| +9% | +$716 | ﹤0.01% | 4511 |
|
|
2013
Q2 | $9K | Buy |
+934
| New | +$10.6K | ﹤0.01% | 4506 |
|
Other funds holding ACUR
Group One Trading's ACUR Position: Q1 2017 in Review
Group One Trading sold out of Acura Pharmaceuticals (ACUR) in Q1 2017, closing a stake of 807 shares — an estimated $1K sold.
Group One Trading first reported a position in ACUR in Q2 2013 and held it in 13 quarters. The position peaked at $10K in Q3 2013. 3 funds tracked by Wall St. Rank hold ACUR as of Q1 2017.
- Group One Trading reported no remaining Acura Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
- Group One Trading sold 807 Acura Pharmaceuticals shares in Q1 2017, an estimated $1K.
- Group One Trading first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 13 quarters.
- Group One Trading's Acura Pharmaceuticals position peaked at $10K in Q3 2013.
- 3 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2017.
Based on Group One Trading's 13F filing for Q1 2017, filed 10 May 2017.